Nitrofurantoin Kora Healthcare

This information is specific to Ireland and is not intended to replace the advice of a healthcare professional. Please consult your healthcare professional for further advice and information on your condition and medication.

Nitrofurantoin Kora Healthcare is indicated in infections of the urinary tract that are caused by micro-organisms sensitive to nitrofurantoin.

• In acute uncomplicated lower urinary tract infections.
• For short-term prophylaxis after surgical procedures, transurethral interventions, catheterization, cystoscopy and indwelling catheter;
• For long-term treatments of urinary tract infections up to 6 months; longer than 6 months only if the benefits clearly outweigh the potential risks. In view of the side effects, long-term therapy should only be used if no suitable alternative is available.

Nitrofurantoin Kora Healthcare is indicated in adults and children (aged over 5 years). Consideration should be given to official guidance on the appropriate use of antibacterial agents

Presentation: Nitrofurantoin Kora Healthcare hard capsules are available in two strengths, containing either 50 mg or 100 mg of nitrofurantoin.

Marketing Authorisation Holder: 

Kora Corporation Limited t/a Kora Healthcare
20 Harcourt Street
Dublin
D02 H364
Ireland

Manufacturer:

IASIS PHARMACEUTICALS HELLAS ΑΒΕΕ, 137, Filis Ave, Kamatero, Attiki, 13451,

Greece.

IASIS PHARMACEUTICALS HELLAS S.A. – KOROPI, Archimidous Street, Koropi Attikis,

19 400 Greece

Date of Preparation: March 2025

#164167